Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2009; Volume 195, Supplement 669
The 88th Annual Meeting of The German Physiological Society
3/22/2009-3/25/2009
Giessen, Germany


PIP5K2A-DEPENDENT REGULATION OF THE EXCITATORY AMINO ACID TRANSPORTER EAAT3
Abstract number: O303

Tang1 C., Fedorenko1 O., Strutz-Seebohm1 N., Ureche1 O. N., Ivanova1 S., Semke1 A., Lang1 F., Seebohm1 G., Gruner1 Y., Lang1 U. E.

1Department of Physiology, Eberhard-Karls-University, Tbingen

According to previous observations, the gene encoding the phosphatidylinositol-4-phosphate 5-kinase II alpha (PIP5K2A) is associated with schizophrenia. Specifically, the mutation N251SPIP5K2A has been discovered in schizophrenic partients but not in healthy individuals. Defective excitatory amino acid transporter EAAT3 has similarly been implicated in the development of schizophrenia. The present study thus explored, whether PIP5K2A is involved in the regulation of EAAT3 activity. EAAT3 has been expressed in Xenopus oocytes either without or with PIP5K2A and EAAT3 transporter activity estimated from glutamate (2 mM) induced current (Iglu) in dual voltage clamp experiments. In EAAT3 expressing oocytes, Iglu was enhanced by coexpression of wild type PIP5K2A. Coexpression of the schizophrenia associated mutant N251SPIP5K2A significantly decreased Iglu in both, oocytes expressing EAAT3 or both, EAAT3 and wild type PIP5K2A. Thus, N251SPIP5K2A exerts a dominant inhibitory effect. Injection of PI(4,5)P2 increaseed Iglu in oocytes expressing EAAT3 alone, but not in oocytes expressing EAAT3 and PIP5K2A. The present observation discloses a novel mechanism of EAAT3 regulation, which may contribute to the deranged regulation of excitability in schizophrenic patients.

To cite this abstract, please use the following information:
Acta Physiologica 2009; Volume 195, Supplement 669 :O303

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE